Home/Deepcell/Janette Phi
JP

Janette Phi

Chief Business Officer

Deepcell

Therapeutic Areas

Deepcell Pipeline

DrugIndicationPhase
REM-i Platform for Oncology ResearchTumor Heterogeneity, Rare Cancer Cell AnalysisResearch-Use Only
REM-i Platform for Cell & Gene Therapy QCManufacturing Process MonitoringDevelopment/Partnership
Partnership with InGel TherapeuticsNext-Generation Ocular Cell TherapiesPre-clinical/Development